Continuing their good works, the folks at gSource, LLC have made another donation of their surgical instruments to the Foundation of Orthopedics and Complex Spine (FOCOS) in Accra, Ghana. The instruments are valued at $9, 496; this brings the total amount donated to FOCOS by gSource to $44, 768.
gSource Donates Surgical Instruments to FOCOS…Again!

Billmann told OTW, “gSource is pleased to help FOCOS continue improving the lives of thousands of individuals by providing the FOCOS Orthopedic Hospital in Ghana with the highest quality instruments needed for the complicated surgeries performed. gSource instruments are crafted from German stainless steel and are recognized by their finely finished surface. They are also designed to perform with precise surgical function. We remain committed to putting the finest instruments into the hands of the FOCOS volunteer surgeons who are dedicated to helping those in need.”
“Our recent donation to FOCOS included various retractors used in shoulder surgery, such as fukuda, capsule, humeral head, and rotator cuff. In addition, we donated hemostatic and tissue forceps needed in many types of surgeries performed.”
Founded in 1998 by famed spine surgeon Oheneba Boachie-Adjei, M.D., FOCOS strives to provide optimum orthopedic care and improve quality of life in Ghana and other countries. To date, FOCOS surgeons have performed over 1, 500 corrective orthopedic and joint procedures for adult and pediatric populations. In April 2012, the 50-bed FOCOS Orthopedic Hospital in Accra, Ghana opened its doors.

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.